Prognostic value of amyloid PET scan in normal pressure hydrocephalus

Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus

(2016) Hiroaki Kazui et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus

(2015) Kotaro Hiraoka et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Preoperative Prognostic Value of MRI Findings in 108 Patients with Idiopathic Normal Pressure Hydrocephalus

(2014) J. Virhammar et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Evaluation of coexistence of Alzheimer’s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers

(2014) Tae Sung Lim et al.   BMC Neurology

Cognitive functions after spinal tap in patients with normal pressure hydrocephalus

(2014) H. Schmidt et al.   JOURNAL OF NEUROLOGY

Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus

(2014) N. R. Graff-Radford   NEUROLOGY

Positron emission tomography with [18F]flutemetamol and [11C]PiB forin vivodetection of cerebral cortical amyloid in normal pressure hydrocephalus patients

(2013) V. Leinonen et al.   EUROPEAN JOURNAL OF NEUROLOGY

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

(2012) Juha O. Rinne et al.   ACTA NEUROPATHOLOGICA

An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients

(2012) Dean F. Wong et al.   MOLECULAR IMAGING AND BIOLOGY

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls

(2011) Henryk Barthel et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias

(2011) V. L. Villemagne et al.   JOURNAL OF NUCLEAR MEDICINE

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

(2011) Henryk Barthel et al.   LANCET NEUROLOGY

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

(2010) Roy Hamilton et al.   ANNALS OF NEUROLOGY

Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients

(2010) Hyun-Jung Ahn et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY